The results in present study demonstrate that treating neuroblastoma cells with SsnB (10 μM) resulted in cell cycle block in G2/M phase (flow cytometry analysis, Figure 1C) and increase in expression of p53 compared to DMSO treated cells (Figure 3G). The gene discussed is TP53; the disease is neuroblastoma.